
AiChemist is a research project funded by the European Union's Horizon Europe program under the Marie Skłodowska-Curie grant. It focuses on optimizing biological activity and ADME properties of new compounds while minimizing toxicity using advanced machine learning techniques. The project develops and benchmarks representation learning approaches to improve accuracy and explainability, leveraging both public and proprietary data. AiChemist collaborates with major pharmaceutical and research institutions across Europe, positioning itself at the intersection of AI and drug discovery to enhance compound development processes.

AiChemist is a research project funded by the European Union's Horizon Europe program under the Marie Skłodowska-Curie grant. It focuses on optimizing biological activity and ADME properties of new compounds while minimizing toxicity using advanced machine learning techniques. The project develops and benchmarks representation learning approaches to improve accuracy and explainability, leveraging both public and proprietary data. AiChemist collaborates with major pharmaceutical and research institutions across Europe, positioning itself at the intersection of AI and drug discovery to enhance compound development processes.